Found: 70
Select item for more details and to access through your institution.
Long‐term safety and efficacy of filgotinib for the treatment of moderately to severely active ulcerative colitis: Interim analysis from up to 4 years of follow‐up in the SELECTION open‐label long‐term extension study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 5, p. 563, doi. 10.1111/apt.18158
- By:
- Publication type:
- Article
Patient preferences for adalimumab in inflammatory bowel disease: a nationwide study from the GETAID.
- Published in:
- Therapeutic Advances in Gastroenterology, 2024, p. 1, doi. 10.1177/17562848241265776
- By:
- Publication type:
- Article
Long‐term risk of delayed postoperative Crohn's disease recurrence in patients with no or mild endoscopic recurrence at first assessment.
- Published in:
- European Journal of Clinical Investigation, 2024, v. 54, n. 8, p. 1, doi. 10.1111/eci.14219
- By:
- Publication type:
- Article
Pragmatic Trial Design to Compare Real-world Effectiveness of Different Treatments for Inflammatory Bowel Diseases: The PRACTICE-IBD European Consensus.
- Published in:
- Journal of Crohn's & Colitis, 2024, v. 18, n. 8, p. 1222, doi. 10.1093/ecco-jcc/jjae026
- By:
- Publication type:
- Article
Lymphoma in Patients with Inflammatory Bowel Disease: A Multicentre Collaborative Study Between GETAID and LYSA.
- Published in:
- Journal of Crohn's & Colitis, 2024, v. 18, n. 4, p. 533, doi. 10.1093/ecco-jcc/jjad177
- By:
- Publication type:
- Article
Simulated cost‐effectiveness of a novel precision‐guided dosing strategy in adult patients with Crohn's disease initiating infliximab maintenance therapy.
- Published in:
- Pharmacotherapy, 2024, v. 44, n. 4, p. 331, doi. 10.1002/phar.2915
- By:
- Publication type:
- Article
Méthotrexate et MICI : mode d'action, indications/utilisation.
- Published in:
- Hépato-Gastro & Oncologie Digestive, 2024, v. 31, p. 8, doi. 10.1684/hpg.2024.2716
- By:
- Publication type:
- Article
Letter: Should ulcerative colitis be monitored more or less invasively?
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 5, p. 721, doi. 10.1111/apt.17873
- By:
- Publication type:
- Article
Nouvelles stratégies thérapeutiques dans la colite aiguë sévère à l'ère des biothérapies et des anti-JAK.
- Published in:
- Hépato-Gastro & Oncologie Digestive, 2024, v. 31, n. 3, p. 333, doi. 10.1684/hpg.2024.2741
- By:
- Publication type:
- Article
The risk of COVID-19 in IBD patients is increased by urban living and is not influenced by disease activity or intravenous biologics.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1243898
- By:
- Publication type:
- Article
Should we Target Complete Endoscopic Healing in Patients with Acute Severe Ulcerative Colitis?
- Published in:
- Journal of Crohn's & Colitis, 2023, v. 17, n. 7, p. 1169, doi. 10.1093/ecco-jcc/jjad032
- By:
- Publication type:
- Article
ECCO Guidelines on Inflammatory Bowel Disease and Malignancies.
- Published in:
- Journal of Crohn's & Colitis, 2023, v. 17, n. 6, p. 827, doi. 10.1093/ecco-jcc/jjac187
- By:
- Publication type:
- Article
Prise en charge d'une colite aiguë grave.
- Published in:
- Hépato-Gastro & Oncologie Digestive, 2023, v. 30, p. 37, doi. 10.1684/hpg.2023.2561
- By:
- Publication type:
- Article
Preoperative Predictors of Neoplasia in Patients Undergoing Small Bowel Resection for Complicated Crohn's Disease: A Multicentre Case-Control Study.
- Published in:
- Cancers, 2023, v. 15, n. 7, p. 2004, doi. 10.3390/cancers15072004
- By:
- Publication type:
- Article
Effectiveness and safety of risankizumab induction therapy for 100 patients with Crohn's disease: A GETAID multicentre cohort study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 4, p. 426, doi. 10.1111/apt.17358
- By:
- Publication type:
- Article
Management of Inflammatory Bowel Disease in Patients with Current or Past Malignancy.
- Published in:
- Cancers, 2023, v. 15, n. 4, p. 1083, doi. 10.3390/cancers15041083
- By:
- Publication type:
- Article
Correction: Efficacy of ustekinumab, vedolizumab, or a second anti-TNF agent after the failure of a first anti-TNF agent in patients with Crohn's disease: a multicentre retrospective study.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Comparison of the Risk of Crohn's Disease Postoperative Recurrence Between Modified Rutgeerts Score i2a and i2b Categories: An Individual Patient Data Meta-analysis.
- Published in:
- Journal of Crohn's & Colitis, 2023, v. 17, n. 2, p. 269, doi. 10.1093/ecco-jcc/jjac137
- By:
- Publication type:
- Article
Editorial: selecting therapy for ulcerative colitis—think a step ahead.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
Efficacy of ustekinumab, vedolizumab, or a second anti-TNF agent after the failure of a first anti-TNF agent in patients with Crohn's disease: a multicentre retrospective study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Iron Deficiency in Patients with Inflammatory Bowel Diseases: A Prospective Multicenter Cross-Sectional Study.
- Published in:
- Digestive Diseases & Sciences, 2022, v. 67, n. 12, p. 5637, doi. 10.1007/s10620-022-07474-z
- By:
- Publication type:
- Article
Quand faire une ponction biopsie hépatique ?
- Published in:
- Hépato-Gastro & Oncologie Digestive, 2022, v. 29, n. 8, p. 957, doi. 10.1684/hpg.2022.2439
- By:
- Publication type:
- Article
Prevalence of Self-Reported Venous Thromboembolism and Cardiovascular Risk Factors in Patients with Ulcerative Colitis: The GETAID FOCUS Study.
- Published in:
- Digestive Diseases & Sciences, 2022, v. 67, n. 9, p. 4525, doi. 10.1007/s10620-022-07445-4
- By:
- Publication type:
- Article
Male gender is associated with informal caregiver burden in patients with chronic intestinal failure treated with home parenteral nutrition.
- Published in:
- JPEN Journal of Parenteral & Enteral Nutrition, 2022, v. 46, n. 7, p. 1593, doi. 10.1002/jpen.2340
- By:
- Publication type:
- Article
Efficacité des traitements actuels chez les patients en échec d'un anti-TNF en première ligne.
- Published in:
- Hépato-Gastro & Oncologie Digestive, 2022, v. 29, p. 9, doi. 10.1684/hpg.2022.2387
- By:
- Publication type:
- Article
IgA vasculitis in patients with inflammatory bowel disease: new insights into the role of TNF-α blockers.
- Published in:
- Rheumatology, 2022, v. 61, n. 5, p. 1957, doi. 10.1093/rheumatology/keab662
- By:
- Publication type:
- Article
A single dedicated vaccination visit improves vaccination coverage of patients with inflammatory bowel disease.
- Published in:
- Therapeutic Advances in Gastroenterology, 2022, v. 15, p. 1, doi. 10.1177/17562848221082879
- By:
- Publication type:
- Article
Compliance with Gluten Free Diet Is Associated with Better Quality of Life in Celiac Disease.
- Published in:
- Nutrients, 2022, v. 14, n. 6, p. 1210, doi. 10.3390/nu14061210
- By:
- Publication type:
- Article
Editorial: don't forget basic performance measures in the endoscopic assessment of ulcerative colitis.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Prise en charge des fistules ano-périnéales au cours de la maladie de Crohn, actualisation 2021 du consensus de la Société Nationale Française de Colo-Proctologie.
- Published in:
- Hépato-Gastro & Oncologie Digestive, 2021, v. 28, n. 9, p. 1052, doi. 10.1684/hpg.2021.2249
- By:
- Publication type:
- Article
Effectiveness and safety of ustekinumab maintenance therapy in 103 patients with ulcerative colitis: a GETAID cohort study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 54, n. 7, p. 944, doi. 10.1111/apt.16544
- By:
- Publication type:
- Article
Colonic Strictures in Inflammatory Bowel Disease: Epidemiology, Complications, and Management.
- Published in:
- Journal of Crohn's & Colitis, 2021, v. 15, n. 10, p. 1766, doi. 10.1093/ecco-jcc/jjab068
- By:
- Publication type:
- Article
Tofacitinib as salvage therapy for 55 patients hospitalised with refractory severe ulcerative colitis: A GETAID cohort.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 54, n. 3, p. 312, doi. 10.1111/apt.16463
- By:
- Publication type:
- Article
Letter: is the radiation therapy causing an IBD flare, or the IBD predisposing to radiation toxicity? Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 53, n. 7, p. 857, doi. 10.1111/apt.16300
- By:
- Publication type:
- Article
Editorial: is enteral nutrition back in acute severe ulcerative colitis?
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 53, n. 6, p. 745, doi. 10.1111/apt.16260
- By:
- Publication type:
- Article
Effectiveness and Safety of Ustekinumab Intensification at 90 mg Every 4 Weeks in Crohn's Disease: A Multicentre Study.
- Published in:
- Journal of Crohn's & Colitis, 2021, v. 15, n. 2, p. 222, doi. 10.1093/ecco-jcc/jjaa177
- By:
- Publication type:
- Article
Modelling of the relationship between infliximab exposure, faecal calprotectin and endoscopic remission in patients with Crohn's disease.
- Published in:
- British Journal of Clinical Pharmacology, 2021, v. 87, n. 1, p. 106, doi. 10.1111/bcp.14364
- By:
- Publication type:
- Article
Editorial: biologics in the therapy of Crohn's disease—the fog clears.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 7, p. 1214, doi. 10.1111/apt.16005
- By:
- Publication type:
- Article
Treatment Algorithm for Mild and Moderate-to-Severe Ulcerative Colitis: An Update.
- Published in:
- Digestion, 2020, v. 101, p. 2, doi. 10.1159/000504092
- By:
- Publication type:
- Article
Altered sleep quality is associated with Crohn's disease activity: an actimetry study.
- Published in:
- Sleep & Breathing, 2020, v. 24, n. 3, p. 971, doi. 10.1007/s11325-019-01934-z
- By:
- Publication type:
- Article
Concise Commentary: Spaced Out-Reducing the Relapse Risk in IBD Patients by Lengthening Dosing Intervals of Anti-TNFs.
- Published in:
- 2020
- By:
- Publication type:
- editorial
Maintenance of Remission Among Patients With Inflammatory Bowel Disease After Vedolizumab Discontinuation: A Multicentre Cohort Study.
- Published in:
- Journal of Crohn's & Colitis, 2020, v. 14, n. 7, p. 896, doi. 10.1093/ecco-jcc/jjaa005
- By:
- Publication type:
- Article
Effectiveness and safety of ustekinumab induction therapy for 103 patients with ulcerative colitis: a GETAID multicentre real‐world cohort study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 11, p. 1039, doi. 10.1111/apt.15717
- By:
- Publication type:
- Article
Comparative efficacy and safety of vedolizumab and infliximab in ulcerative colitis after failure of a first subcutaneous anti‐TNF agent: a multicentre cohort study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 9, p. 852, doi. 10.1111/apt.15680
- By:
- Publication type:
- Article
Prise en charge des maladies inflammatoires chroniques de l'intestin à l'heure de l'épidémie COVID-19.
- Published in:
- Hépato-Gastro & Oncologie Digestive, 2020, v. 27, n. 5, p. 498, doi. 10.1684/hpg.2020.1980
- By:
- Publication type:
- Article
Therapeutic Drug Monitoring of Biologics During Induction to Prevent Primary Non-Response.
- Published in:
- Journal of Crohn's & Colitis, 2020, v. 14, n. 4, p. 542, doi. 10.1093/ecco-jcc/jjz162
- By:
- Publication type:
- Article
Concise Commentary: Second Line Is Not Second Best-Continuing Validity of the Oxford Criteria in the Management of Acute Severe Ulcerative Colitis.
- Published in:
- 2020
- By:
- Publication type:
- editorial
Letter: should we intensify infliximab in acute severe ulcerative colitis?
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 1, p. 186, doi. 10.1111/apt.15520
- By:
- Publication type:
- Article
Vedolizumab Therapy is Ineffective for Primary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease: A GETAID Multicentre Cohort Study.
- Published in:
- Journal of Crohn's & Colitis, 2019, v. 13, n. 10, p. 1239, doi. 10.1093/ecco-jcc/jjz088
- By:
- Publication type:
- Article
État des lieux sur les MICI en France : Enquête nationale du GETAID.
- Published in:
- Hépato-Gastro & Oncologie Digestive, 2019, v. 26, n. 2, p. 167, doi. 10.1684/hpg.2019.1751
- By:
- Publication type:
- Article